Interim Report January – June 2020
Second quarter 2020 · Net sales amounted to SEK 244.7 million (222.3), an increase of 10% (excluding foreign exchange effects, 8%). Product sales, net sales excluding royalty revenues, amounted to SEK 238.2 million (218.4), an increase of 9% (excluding foreign exchange effects, 7%). · Net sales in the Paediatrics segment reached SEK 199.2 million (181.1), an increase of 10%. · Net sales in the Adult Health segment amounted to SEK 44.4 million (40.9), an increase of 8%. · Operating expenses amounted to SEK 84.2 million (84.9), a decrease of 1%. · Operating profit increased